BMI View: Mexico’s encouraging macroeconomic growth prospects, business-friendly environment and improving pharmaceutical regulatory regime have made it an increasingly attractive market to multinationals. Apart from the ageing population and the increasing incidence of chronic diseases, the government’s commitment to improve its healthcare services is another fundamental factor driving market growth. In addition, its unparalleled policies in market accessibility have made Mexico an important hub for multinationals to enter other Latin American countries. Headline Expenditure Projections ? Pharmaceuticals: MXN176.00bn (US$13.38bn) in 2012 to MXN191.71bn (US$15.10bn) in 2013; +8.9% in local currency terms and +12.8% in US dollar terms. Forecast increased from …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=130042.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/mexico-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment